| Companies sponsors |
Merck Sharp & Dohme (pembrolizumab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Peaches Womb Cancer Trust |
| Professional groups |
Association of Anaesthetists |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Comparator companies |
Accord (carboplatin, paclitaxel, cisplatin, doxorubicin) CAU not signed (not participating) |
| |
Alliance Healthcare (cyclophosphamide, paclitaxel) CAU not signed (not participating) |
| |
Bausch & Lomb (megestrol acetate) CAU not signed (not participating) |
| |
Baxter Healthcare (cyclophosphamide) CAU not signed (not participating) |
| |
Bristol Myers Squibb Pharmaceuticals (paclitaxel) CAU not signed (not participating) |
| |
Consilient Health (carboplatin) CAU not signed (not participating) |
| |
Fresenius Kabi (carboplatin, paclitaxel) CAU not signed (not participating) |
| |
Hospira UK (carboplatin, paclitaxel) CAU not signed (not participating) |
| |
Johnson & Johnson Innovative Medicine (doxorubicin) CAU not signed (not participating) |
| |
Medac GmbH (doxorubicin) CAU not signed (not participating) |
| |
Novartis (cisplatin, cyclophosphamide) CAU not signed (not participating) |
| |
Pfizer (carboplatin, paclitaxel, cisplatin, doxorubicin, medroxyprogesterone acetate) CAU not signed (not participating) |
| |
Sandoz (cyclophosphamide) CAU not signed (not participating) |
| |
Seacross Pharmaceuticals (paclitaxel, doxorubicin) CAU not signed (not participating) |
| |
Teva UK (carboplatin, paclitaxel) CAU not signed (not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |